INSIGHTS ON DRUG DEVELOPMENT
-
Advancing Drug Safety And Improving R&D Productivity With The Liver-Chip S1
Explore how the Emulate Liver-Chip S1 revolutionizes predictive toxicology by mimicking human liver biology, achieving superior sensitivity and specificity.
-
Leveraging Early Insights To Accelerate The Oral Drug Development Cycle
Consider how the following early development insights can help you navigate complex oral drug development and move your program forward with greater confidence.
-
Leveraging Softgel To Extend Vinorelbine's Lifecycle, Improve Patient Convenience
Develop innovative oral formulations of traditionally intravenous therapies to enhance patient convenience, ensure consistent systemic exposure, and support long-term brand value and market differentiation.
-
Biologic Stability: A Thermofluor Screen For Rational Buffer Optimization
Learn how thermal shift fluorimetry (thermofluor) can be used as a rapid, low-volume, and cost-effective technique to accelerate buffer optimization and enhance protein stability.
-
Building A Human-Centric Future For Biologics Development6/25/2026
Biologics are advancing rapidly, but complexity challenges traditional models. Gain insight into how human-relevant approaches like NAMs and microphysiological systems are gaining traction.
-
Quicker Development Using Cell Line Integration, End-To-End Support6/19/2025
Despite challenges with mammalian host cell line diversity, Lonza's mitigation strategies drive efficiency and reproducibility, maximizing cell growth and product quality.
-
The History Of Chemical Nomenclature And ACD/Name6/18/2026
Modern chemical naming requires algorithmic precision to match evolving standards and new compound classes. Up-to-date nomenclature ensures regulatory compliance and seamless workflow integration.
-
Suitability Testing For IVT mRNA Analysis11/20/2025
Automated capillary electrophoresis provides robust, precise analysis of IVT mRNA integrity, concentration, and size, demonstrating excellent method precision.
-
Direct qPCR Amplification From Human Urine Samples6/9/2026
Extraction-free qPCR enables faster, lower-cost detection of UTI-associated bacteria directly from urine samples. Explore how this approach simplifies workflows and accelerates time to results.
DRUG DEVELOPMENT SOLUTIONS
-
Enhance your protein production with a next-generation feed specifically designed to boost the performance of CHO-K1 GS cell lines.
-
Accelerate your gene therapy manufacturing with the Xcellerex™ X-platform – a next-generation single-use bioreactor system designed for viral vector workflows.
-
We deliver custom assay development, screening, potency, and selectivity testing services for the pharmaceutical, biopharmaceutical, and agrochemical industries.
-
We simplify pre-production workflows—for both upstream and downstream—by delivering fit-for-purpose process liquid and buffer preparation solutions that enable you to produce life-changing therapeutics and vaccines, faster.
-
We offer a comprehensive method optimization service to take early stage development methods with poor stability indication, excessive run time lengths, or legacy column chemistries and modify them.